GRAPPA 2013 basic/translational/clinical science update: Comorbidity monitoring

Journal of Rheumatology

Volumn 41, Issue 6, 2014, Pages 1224-1226

  Boehncke, Wolf Henning ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Cardiovascular risk; Comorbidities; Mortality; Myocardial infarction; Psoriasis; Screening

Indexed keywords

ALCOHOL CONSUMPTION; ANXIETY; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHECKLIST; CLINICAL PRACTICE; CLINICAL PROTOCOL; COMORBIDITY; CONFERENCE PAPER; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; INFLAMMATORY BOWEL DISEASE; LIPID BLOOD LEVEL; LYMPHOMA; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OPPORTUNISTIC INFECTION; OSTEOPOROSIS; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; RISK ASSESSMENT; TOBACCO CONSUMPTION; UPPER RESPIRATORY TRACT INFECTION; WAIST CIRCUMFERENCE; CARDIOVASCULAR DISEASES; COMPLICATION; RISK FACTOR;

ARTHRITIS, PSORIATIC; CARDIOVASCULAR DISEASES; HUMANS; PSORIASIS; RISK FACTORS;

EID: 84901716392     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.140175     Document Type: Conference Paper

References (12)

1. Boehncke WH, Boehncke S, Schon MP. Managing comorbid disease in patients with psoriasis. BMJ 2010;340:b5666.
2. Dauden E, Castaneda S, Suarez C, Garcia-Campayo J, Blasco AJ, Aguilar MD, et al. Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis. J Eur Acad Dermatol Venereol 2013;27:1387-404.
3. Husni ME, Mease PJ. Managing comorbid disease in patients with psoriatic arthritis. Curr Rheumatol Rep 2010;12:281-7.
4. Boehncke WH, Boehncke S. [Comorbidities in psoriatic arthritis.] Z Rheumatol 2013;72:779-83.
5. Abuabara K, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J Dermatol 2010;163:586-92.
6. Boehncke WH, Boehncke S, Tobin AM, Kirby B. The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol 2011;20:303-7.
7. Jamnitski A, Symmons D, Peters MJ, Sattar N, McInnes I, Nurmohamed MT. Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis 2013;72:211-6.
8. Kimball AB, Gladman D, Gelfand JM, Gordon K, Horn EJ, Korman NJ, et al. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol 2008;58:1031-42.
9. Boehncke WH, Boehncke S. Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives. Curr Rheumatol Rep 2012;14:343-8.
10. Nast A, Boehncke WH, Mrowietz U, Ockenfels HM, Philipp S, Reich K, et al. S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update. J Dtsch Dermatol Ges 2012;10 Suppl 2:S1-95.
11. Boehncke WH, Menter A. Burden of disease: psoriasis and psoriatic arthritis. Am J Clin Dermatol 2013;14:377-88.
12. Parsi KK, Brezinski EA, Lin TC, Li CS, Armstrong AW. Are patients with psoriasis being screened for cardiovascular risk factors? A study of screening practices and awareness among primary care physicians and cardiologists. J Am Acad Dermatol 2012;67:357-62.